5AM Venture Management’s Vor Biopharma VOR Stock Holding History

5AM Venture Management’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-318,086	Closed	-$10.3M	–	29
2025 Q2	$10.3M	Hold	318,086	–	–	3.96%	8
2025 Q1	$4.56M	Hold	318,086	–	–	1.73%	21
2024 Q4	$7.06M	Hold	318,086	–	–	1.69%	19
2024 Q3	$4.45M	Hold	318,086	–	–	0.92%	22
2024 Q2	$6.36M	Hold	318,086	–	–	1.42%	20
2024 Q1	$15.1M	Hold	318,086	–	–	3.38%	12
2023 Q4	$14.3M	Hold	318,086	–	–	3.8%	10
2023 Q3	$13.5M	Hold	318,086	–	–	3.88%	7
2023 Q2	$19.7M	Hold	318,086	–	–	4.9%	5
2023 Q1	$34.2M	Hold	318,086	–	–	8.75%	3
2022 Q4	$42.3M	Hold	318,086	–	–	11.37%	3
2022 Q3	$25.3M	Hold	318,086	–	–	4.85%	6
2022 Q2	$31.6M	Hold	318,086	–	–	7.82%	3
2022 Q1	$38.4M	Hold	318,086	–	–	8.39%	4
2021 Q4	$73.9M	Sell	318,086 -16,535	-5%	-$4.77M	13.87%	3
2021 Q3	$105M	Hold	334,621	–	–	21.31%	1
2021 Q2	$125M	Hold	334,621	–	–	31.41%	1
2021 Q1	$288M	Buy	+334,621	New	+$283M	51.94%	1

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Ariose Capital Management Central, Hong Kong, Hong Kong $234M AUM 640.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

5AM Venture Management's VOR Position: Q3 2025 in Review

5AM Venture Management sold out of Vor Biopharma (VOR) in Q3 2025, closing a stake of 318,086 shares — an estimated $10.3M sold.

5AM Venture Management first reported a position in VOR in Q1 2021 and held it in 18 quarters. The position peaked at $288M in Q1 2021. 37 funds tracked by Wall St. Rank hold VOR as of Q3 2025.

5AM Venture Management reported no remaining Vor Biopharma position as of Q3 2025 after selling out during the quarter.
5AM Venture Management sold 318,086 Vor Biopharma shares in Q3 2025, an estimated $10.3M.
5AM Venture Management first reported a position in Vor Biopharma in Q1 2021 and held it in 18 quarters.
5AM Venture Management's Vor Biopharma position peaked at $288M in Q1 2021.
37 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2025.

Based on 5AM Venture Management's 13F filing for Q3 2025, filed 14 Nov 2025.